化学
丁酰胆碱酯酶
小分子
荧光
合理设计
药物发现
组合化学
生物化学
生物物理学
酶
乙酰胆碱酯酶
纳米技术
生物
物理
量子力学
材料科学
阿切
作者
Lei Wang,Chenxi Du,Hui Liu,Weimin Qiu,Xin Lü,Yanyu Hu,Yueqing Li,Tian‐Yu Sun,Chen Yao,Haopeng Sun
标识
DOI:10.1002/cjoc.202100910
摘要
Comprehensive Summary Butyrylcholinesterase (BChE) is regarded as a promising target for the treatment of Alzheimer's disease (AD), as its level significantly increases along with the progress of this disease. Therefore, the development of potent and high‐affinity small‐molecule BChE inhibitors may be a new strategy for the discovery of anti‐AD drugs. However, the current Ellman's method is unable to evaluate the affinity of compounds with BChE, and has a few deficiencies in drug development. Herein, the first small‐molecule fluorescence polarization (FP) probes for BChE were rationally designed based on a high affinity inhibitor. Studies indicated that probe F6 exhibited satisfactory fluorescence intensity and suitable fluorescent properties that were compatible with the filters in the FP system. Meanwhile, probe F6 exhibited potent binding affinity to BChE. It is feasible to be applied in detecting the affinity of non‐fluorescent compounds to BChE, which lays a solid foundation for the development of small‐molecule BChE inhibitors. At the same time, it also can be applied as a valuable chemical tool for better understanding the molecular biological mechanism of BChE.
科研通智能强力驱动
Strongly Powered by AbleSci AI